Pap smear screening among the postmenopausal women

BULGULAR: Pap smear sonuçları 1320 hastada normal, 591 hastada inflamasyon, 121 hastada atrofi, 22 hastada metaplazi, 4 hastada ASCUS, 1 hastada HGSIL ve 1 hastada karsinom olarak rapor edildi.

📌 3 Maddede Bu Makale

🎯

Amaç & Hipotez:AMAÇ: Postmenopozal kadınlarda Pap smear taramasının etkinliğini değerlendirmek.

📊

Temel Bulgular & Veri:GEREÇ VE YÖNTEM: Menopoz polikliniğine başvuran 2060 kadın retrospektif olarak incelendi.

💡

Sonuç & Katkı:BULGULAR: Pap smear sonuçları 1320 hastada normal, 591 hastada inflamasyon, 121 hastada atrofi, 22 hastada metaplazi, 4 hastada ASCUS, 1 hastada HGSIL ve 1 hastada karsinom olarak rapor edildi.

🔬Tür:Araştırma Makalesi

📍Kapsam:2060 · 1320 hasta

⚙️Değişkenler:Alan Parametreleri

Özet

AMAÇ: Postmenopozal kadınlarda Pap smear taramasının etkinliğini değerlendirmek. GEREÇ VE YÖNTEM: Menopoz polikliniğine başvuran 2060 kadın retrospektif olarak incelendi. Hastaların demografik özellikleri, hormon tedavisi kullanıp kullanmadıkları ve daha önce Pap smear alınma öyküsü kaydedildi. BULGULAR: Pap smear sonuçları 1320 hastada normal, 591 hastada inflamasyon, 121 hastada atrofi, 22 hastada metaplazi, 4 hastada ASCUS, 1 hastada HGSIL ve 1 hastada karsinom olarak rapor edildi. Pap smear sonucu ASCUS olarak rapor edilen dört hastadan ikisinin daha önce normal olarak rapor edilmiş Pap smear sonuçları varken, diğer iki HGSIL ve karsinom olgusunda Pap smear taraması yapılmamıştı. ASCUS olgularına kolposkopi yapıldı ve üç tanesinde normal kolposkopi bulguları mevcuttu. HGSIL olgusuna yapılan servikal biyopsi sonucu ise yassı hücreli karsinom olarak rapor edildi. SONUÇ: Postmenopozal kadınlara düşük etkinliğe veya yanlış pozitif sonuçlara rağmen Pap smear taraması yapılmalıdır.

Abstract

OBJECTIVE: To evaluate the effectiveness of routine Pap smear screening in postmenopausal women. STUDY DESIGN: 2060 women applied to menopause outpatient clinic were reviewed retrospectively. Demographic characteristics, the use of hormone therapy, and the history of previous Pap smear were analyzed. RESULTS: The Pap smear results were as; normal in 1320, inflammation in 591, atrophy in 121, metaplasia in 22, ASCUS in 4, HGSIL in 1, and carcinoma in 1. While two of the ASCUS patients had two previous cervical smears which were normal; the other two HGSIL and carcinoma patient had not previous Pap smear. The patients who had ASCUS, colposcopy was applied and three of them were normal. The histopathological analysis of the cervical biopsy in the HGSIL case was squamous cell carcinoma. CONCLUSION: Pap smear screening should be done to postmenopausal women in spite of low efficiency or false positive results.

🔖

Bu Makaleye Atıf Yap

DEMİR, B., HABERAL, A., ÖZTÜRKOĞLU, E., DÜNDAR, B., BASKAN, B., SOBACI, E., ÖZGÜL, N. (2010). Pap smear screening among the postmenopausal women. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 16 - Sayı: 3, 168–171. https://ajindex.com/articles/227048

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

McCrory DC, Matchar DB, Bastian L, Datta S, Hasselblad V, Hickey J et al. Evaulation of cervical cytology. Evidence Rep Technol Assess. 1999;(5):1-6
Ries LAG, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK. SEER Cancer Statistics Review, 1973-1996. Bethesta, Md: National Cancer Institute, 1999
Sung HY, Kearney KA, Miller M, Kinney W, Sawaya GF, Hiatt RA. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer 2000;88:2283-9
NIH Consensus Statement. Cervical Cancer. Washington, DC. US Dept of Health and Services,1996
Van Wijngaarden WJ, Duncan ID: Rationale for stopping cervical screening in women over 50. BMJ 1993;306: 967-71
Cruickshank ME, Angus V, Kelly M, McPhee S, Kitchener HC. The case for stopping cervical screening at age 50. Br J Obstet Gyaecol 1997;104: 586-9
Thomas A, Correa MM, Kumar KR. Clinical profile and cervical cytomorphology in symptomatic postmenopausal women. Indian J Pathol Microbiol 2003; 46(2):176-9
Sawaya GF, Grady D, Kerlikowske K. The positive predictive value of cervical smears in previously screened postmenopausal women: The Heart and Estrogen/progestin replacement study (HERS). Ann Intern Med 2000; 133:942-50
The 2001 Bethesda System. Terminology for reporting results of cervical cytology. JAMA 2002; 287(16): 2114-9
Benard VB, Eheman CR, Lawson HW. Cervical screening in the National Breast and Cervical Cancer Early Detection Program. 1995-2001. Obstetrics and Gynecology 2004;103(3): 564-71. 11. van Ballegooijen M, van den Akker-van Marle E, Patnick J, Lynge E, Arbyn M, Anttila A et al. Overview of important cervical cancer screening process values in European Union countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. Eur J Cancer 2000;30:2177-88
Schiffman MH. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 1992;84:394-98
Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, Cohen C. American Cancer Society Guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-62
Kietpeerakool C, Sukkawattananon W, Srisomboon J, Khunamompong S, Siriaunkgul S, Nimmanhaemindak K. Factors predicting occult invasive carcinoma in women undergoing a ‘see and treat’ approach. Asian Pac J Cancer Prev. 2008;9(2):209-12
Gustafsson L, Ponten J, Bergstrom